Refludan anvendes til antikoagulation (hæmning af blodpropdannelse) hos voksne patienter med heparin- induceret trombocytopeni (HIT, er en slags allergi overfor heparin, hvilket medfører blodplademangel eller blodpropper i blodkarrene) samt tromboembolisk sygdom (unormal udvikling af blodpropper), som kræver injiceret antithrombotisk behandling, almindeligvis heparin.
Refludan is used to prevent blood clotting in adult patients with heparin-induced thrombocytopenia (HIT, a certain type of allergy to heparin which causes a lack of platelets in the blood or clots in the blood vessels) and who have thromboembolic disease (abnormal development of blood clots) that needs injected antithrombotic treatment, usually heparin.